Wunderlich Capital Managemnt Abb Vie Inc. Transaction History

Wunderlich Capital Managemnt

$212 Million
Q2 2024

A detailed history of Wunderlich Capital Managemnt transactions in Abb Vie Inc. stock. As of the latest transaction made, Wunderlich Capital Managemnt holds 6,003 shares of ABBV stock, worth $1.06 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

6,003

Previous 5,955 0.81%

Holding current value

$1.06 Million

Previous $1.08 Million 5.07%

% of portfolio

0.49%

Previous 0.51%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $7,429 - $8,676	48 Added 0.81%	6,003 $1.03 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $50,822 - $57,907	-318 Reduced 5.07%	5,955 $1.08 Million
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $179,843 - $202,545	-1,307 Reduced 17.24%	6,273 $972,000
Q3 2023 Nov 15, 2023	BUY	$133.59 - $154.65 $861,655 - $997,492	6,450 Added 570.8%	7,580 $1.13 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $859,651 - $995,172	-6,435 Reduced 85.06%	1,130 $1.13 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $29,417 - $36,607	222 Added 3.02%	7,565 $1.02 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $28,632 - $32,974	198 Added 2.77%	7,343 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $18,533 - $22,226	134 Added 1.91%	7,145 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $75,291 - $86,354	561 Added 8.7%	7,011 $941,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $6,743 - $8,573	-49 Reduced 0.75%	6,450 $988,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $3,431 - $4,257	26 Added 0.4%	6,499 $1.05 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $695,394 - $879,874	6,473 New	6,473 $876,000
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $1.32 Million - $1.69 Million	-20,088 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$77.14 - $90.79 $28,927 - $34,046	375 Added 1.9%	20,088 $1.62 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $3,814 - $4,704	-49 Reduced 0.25%	19,713 $1.82 Million
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $90,777 - $100,915	-1,021 Reduced 4.91%	19,762 $1.87 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $10,504 - $12,428	-117 Reduced 0.56%	20,783 $1.93 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $248,887 - $333,283	-2,705 Reduced 11.46%	20,900 $1.98 Million
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $6,627 - $7,267	-74 Reduced 0.31%	23,605 $2.28 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $1.65 Million - $2.11 Million	23,679	23,679 $2.1 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wunderlich Capital Managemnt, based on Form 13F filings with the SEC.

News

Stay updated on Wunderlich Capital Managemnt with notifications on news.

Account

Wunderlich Capital Managemnt Abb Vie Inc. Transaction History